Standard Error of Empirical Bayes Estimate in NONMEM® VI
暂无分享,去创建一个
Mats O. Karlsson | Radojka M. Savic | Kyun-Seop Bae | Dongwoo Kang | Brett E. Houk | R. Savic | M. Karlsson | B. Houk | K. Bae | D. Kang
[1] R. Savic,et al. Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.
[2] U. Klotz,et al. Generation of Pharmacokinetic Data During Routine Therapeutic Drug Monitoring: Bayesian Approach vs. Pharmacokinetic Studies , 1993, Therapeutic drug monitoring.
[3] M. O. Karlsson,et al. Evaluation of IPPSE, an alternative method for sequential population PKPD analysis , 2012, Journal of Pharmacokinetics and Pharmacodynamics.
[4] M O Karlsson,et al. Diagnosing Model Diagnostics , 2007, Clinical pharmacology and therapeutics.
[5] Yaning Wang,et al. Derivation of various NONMEM estimation methods , 2008, Journal of Pharmacokinetics and Pharmacodynamics.
[6] Lewis B. Sheiner,et al. Use of a Pharmacokinetic/Pharmacodynamic Model to Design an Optimal Dose Input Profile , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[7] Y. Pawitan. In all likelihood : statistical modelling and inference using likelihood , 2002 .
[8] E. Lee,et al. Validity of Bayesian forecasting programme in therapeutic drug monitoring of vancomycin in a surgical intensive care unit: a prospective evaluation. , 1996, Annals of the Academy of Medicine, Singapore.
[9] J. Dimet,et al. Potential Benefit of Bayesian Forecasting for Therapeutic Drug Monitoring in Neonates , 2002, Therapeutic drug monitoring.
[10] Xh Huang,et al. Pharmacometrics: The Science of Quantitative Pharmacology. , 2007 .